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Abstract
Pulmonary surfactant proteins SP-A and SP-D are pattern recognition innate immune mole-
cules. However, there is extrapulmonary existence, especially in the amniotic fluid and at
the feto-maternal interface. There is sufficient evidence to suggest that SP-A and SP-D are
involved in the initiation of labour. This is of great importance given that preterm birth is
associated with increased mortality and morbidity. In this study, we investigated the effects
of recombinant forms of SP-A and SP-D (rhSP-A and rhSP-D, the comprising of trimeric lec-
tin domain) on contractile events in vitro, using a human myometrial cell line (ULTR) as an
experimental model. Treatment with rhSP-A or rhSP-D increased the cell velocity, distance
travelled and displacement by ULTR cells. rhSP-A and rhSP-D also affected the contractile
response of ULTRs when grown on collagen matrices showing reduced surface area. We
investigated this effect further by measuring contractility-associated protein (CAP) genes.
Treatment with rhSP-A and rhSP-D induced expression of oxytocin receptor (OXTR) and
connexin 43 (CX43). In addition, rhSP-A and rhSP-D were able to induce secretion of
GROα and IL-8. rhSP-D also induced the expression of IL-6 and IL-6 Ra. We provide evi-
dence that SP-A and SP-D play a key role in modulating events prior to labour by recondi-
tioning the human myometrium and in inducing CAP genes and pro-inflammatory cytokines
thus shifting the uterus from a quiescent state to a contractile one.
Introduction
Preterm labour is one of the leading causes of perinatal mortality and morbidity, and accounts
for most new-born deaths as well as in children less than 5 years old [1]. Preterm labour is
defined as a birth that takes place prior to the 37th week of gestation. It has been shown to affect
approximately 10% of pregnant women, a figure which continues to rise annually, and its
causes have not yet been fully elucidated [2]. Premature babies face a high risk of disabilities
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and impairments, some of which include respiratory illnesses due to improper lung matura-
tion, cerebral palsy, hearing and visual disabilities [3].
Due to the semi-allogenicity of the foetus, it is crucial for the uterine environment to sustain
pregnancy. Therefore, there seems to be a cross-talk between pro-inflammatory and anti-
inflammatory components for the maintenance of pregnancy and birth [4]. Normal labour is
considered to be a pro-inflammatory event, meaning there is a clear shift towards the end of
term [5]. Surfactant proteins SP-A and SP-D are collagen-containing, Ca2+-dependent C-type
lectins, called collectins and are mainly produced by type II alveolar cells and non-ciliated
bronchiolar epithelial cells [6]. Their primary structure is characterised by an N-terminal, tri-
ple-helical collagen region and a C-terminal carbohydrate recognition domain (CRD) which is
trimerised by a coiled-coil neck region between the collagen and the CRD region [7]. This fam-
ily includes surfactant proteins A (SP-A) and D (SP-D) which can have a dual effect, either
anti-inflammatory or pro-inflammatory, depending on their orientation and the receptors they
bind to [8].
SP-A and SP-D are part of the innate immune system and play a key role in the mainte-
nance of surfactant homeostasis, pathogen clearance, control of inflammation [9], opsonisation
[10], T cell modulation [11], and apoptotic and necrotic cell clearance [12].
There have also been a number of reports confirming an extrapulmonary existence of SP-A
and SP-D [7]. SP-A and SP-D have been localised in the human female reproductive tract and
the uterus, where they are considered to have a role in protection of the tract from infections
[13, 14]. They have been localised in the ovaries, vagina and the cervix [15]. They also appear
to regulate foetal lung maturation for respiratory function and may be involved in the mainte-
nance of pregnancy as they have been found to be present in amniotic fluid after 26 weeks of
gestation with a clear rise towards term [16]. In foetal lungs surfactant production occurs dur-
ing the third semester of pregnancy [17]. SP-A and SP-D have been reported in several extra-
pulmonary tissues and organs such as the digestive system, the brain and the nasal cavity [7].
Condon et al., (2004) [18] have shown that a SP-A gestational increase in amniotic fluid was
followed by an increase of IL-1β and activation of NF-kβ, thus suggesting a labour initiating
role for SP-A in mice. Consistent with the pro-labour properties of SP-A, mice injected with
SP-A had preterm delivery, whereas injection of the polyclonal SP-A antibody in the amniotic
sac delayed parturition by more than 24 h. SP-D, on the other hand, has been found to interact
with decorin, which is the most abundant proteoglycan in foetal membranes and the uterine
cervix. This indicates a potential role of SP-D in intrauterine tissue remodelling during parturi-
tion [19]. Collectively, there is an emerging consensus on the involvement of SP-A and SP-D
during pregnancy and labour. In this study, we sought to investigate the involvement of SP-A
and SP-D in the reconditioning, and contractility of the human myometrium, using a human
myometrial cell line as an experimental model in vitro.
Materials and Methods
Expression of the recombinant forms of homotrimeric CRD regions of
human SP-A (rhSP-A) and SP-D (rhSP-D)
The recombinant fusion proteins SP-A and SP-D were expressed and purified as described pre-
viously [20, 21]. The recombinant proteins containing trimeric lectin domains were expressed
in Escherichia coli BL21 (λDE3) pLysS (Life Technologies, UK). The bacterial cells were grown
in Luria-Bertani medium with 100 μg/ml ampicillin and 34 μg/ml of chloramphenicol, shaking
at 37°C until an A600 of 0.6–0.8 is reached, following an induction with 0.4 mM isopropyl β-
D-thiogalactoside (IPTG), left for 3 h shaking at 37°C. The cells were centrifuged 4500rpm,
4°C, for 10 min. The cell pellet was suspended in lysis buffer (50 mM Tris-HCL pH 7.5,
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200 mMNaCl, 5 mM EDTA, 0.1% v/v Triton X-100, 0.1 mM PMSF, 50 μg lysozyme) for 1
hour, followed by sonication using a Soniprep 150 (MSE, London, UK) at 60 Hz for 30 seconds
with an interval of 2 min (12 cycles), which was then centrifuged at 12000 rpm for 15 min. The
pellet was solubilized in 50 ml buffer A (50 mM Tris-HCl pH 7.5, and 100 mMNaCl) with
10 mM 2-mercaptoethanol (Bio-Rad, Hertfordshire, UK) and 8 M urea for 1 hour at 4°C. The
soluble fraction was dialysed against a gradient of buffer A containing 4 M urea, 2 M urea, and
1 M urea for 2 h at each urea concentration, which was then dialysed against affinity buffer
(50 mM Tris-HCl pH 7.5, 100 mMNaCl, 10 mM CaCl2) externally with 2 changes and then
centrifuged (10,000 rpm, 10 min, 4°C). The supernatant was then passed through 5ml column
of maltose-agarose column, which was washed 3 column volumes of affinity buffer. Bound
SP-D or SP-A were eluted with buffer A consisting of 10 mM EDTA. Samples collected at each
stage of purification were analysed on SDS-PAGE (Fig 1), (Figs A-C in S1 File).
5 ml of Polymyxin B agarose gel (Sigma, Poole, UK) in a 20 ml BioRad column was prepared
to remove LPS of rhSP-A or rhSP-D. The column was washed with 50 ml of 1% sodium deoxy-
cholate and then washed with 50 ml of sterile dH2O. Peak fractions of rhSP-A or rhSP-D were
applied to LPS removal columns for 2 h at 4°C. 1 ml fractions of the flowthrough were collected
of the proteins. The levels of endotoxin were determined by QCL-1000 Limulus amebocyte
lysate system (BioWhittaker, Walkersville, MD, USA). The concentration of protein fractions
was measured at A280 using a NanoDrop. The endotoxin levels were found to be ~ 5 pg μg-1 of
rhSP-D and ~ 4 pg μg-1 of rhSP-A.
Further details of the expression of rhSP-A and its characterisation have been provided as
supplementary material.
Fig 1. A. SDS-PAGE analysis of recombinant SP-A: rhSP-A was expressed in E.coli and purified via maltose agarose column after denaturation and
renaturation process. Lane 1 shows, before induction; lane 2, uninduced; lane 3, induced SPA with IPTG; lane 4, induced SPA with IPTG; lane 5, protein
marker; lane 6, pellet after lysis; lane 7, supernatant after lysis; lane 8, purified peak fraction of SP-A (arrow) after maltose agarose. Fig 1B. SDS-PAGE of
recombinant form of SPD: SPD was expressed in E.coli and purified after denaturation and renaturation process by applying the supernatant to maltose
agarose column. Lane 1 shows, before induction; lane 2, uninduced; lane 3, induction with IPTG; lane 4, supernatant after lysis; lane 5, pellet after lysis; lane
6 and 7 peak fractions of rhSP-D (arrow) after maltose-agarose purification.
doi:10.1371/journal.pone.0143379.g001
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Cell culture and treatments
The myometrial cell line ULTR, which was a kind gift from Dr Xiaolan Cui (Department of
Obstetrics and Gynecology, University of Cincinnati, USA), and was cultured as previously
described [22], in Dulbecco’s modified eagles medium (DMEM) with high glucose (4.5 g/l) and
L-glutamine(0.58 g/l) (Gibco, Life Technologies), supplemented with 1% of penicillin and
streptomycin along with 10% heat inactivated foetal bovine serum (Gibco, Life Technologies),
under standard culture conditions (37° C, 5% CO2). Prior to any experiment or treatment, cells
were grown to approximately 80–90% confluency. Cells were harvested and a cell count was
performed using a haemocytometer. An appropriate amount of cells were seeded depending
on the experiment. Cells were treated with rhSP-A and rhSP-D in a dose- (2.5, 5, 10, 20 μg/ml)
and time- (4, 6, 12, 24 h) dependant manner.
RNA extraction and real time PCR
RNA was extracted from treated and untreated ULTR cells using the Nucleospin kit
(Macherey-nagel, Bethlehem, USA). RNA was quantified using the Nanodrop software by
determining the absorbance at 260 nm. 2 μg of RNA was used to synthesise cDNA using the
Precision nanoScript 2 Reverse Transcription kit (Primerdesign, Southampton, UK). A master-
mix solution consisting of SYBR green mastermix (Primerdesign, Southampton, UK), sterile
water and primers specific for each gene (human SPA-1, SPA-2, SP-D, OXTR, CX43, COX2,
mTOR and DEPTOR; Table 1), was added to a 96-well plate and 1 μl of cDNA was added to
each well. The plate was then sealed, centrifuged and placed into the ABI FAST HT9000 qPCR
machine. Thermocycling conditions for the PCR were denaturation at 98°C for 30 seconds,
30 cycles of [98°C for 10 seconds, 60°C for 30 seconds and 72°C for 30 seconds], and final
extension at 72°C for 10 min. Gene expression levels were normalised to GAPDH levels. All
samples were analysed in triplicates.
Proliferation assay
Cells were grown as described previously, in 75 cm2 flasks and then 150,000 cells were seeded
in 6-well plates. Cells were treated with rhSP-A and rhSP-D (10 μg/ml) for 24 and 48 h prior to
detachment from the flask and dyed with Trypan Blue. Cells were loaded onto slides and then
counted in a Countess Automated Cell Counter (Invitrogen, Life Technologies).
Immunofluorescence microscopy
70,000 cells were then seeded to a 24-well plate that contained coverslips. Cells were left to
adhere for up to 24 h, and then fixed with 4% PFA and permeabilised with 0.5% Triton X-100.
Table 1. Primer sequences of human gene targets used for qPCR experiments.
Gene name Forward primer sequence 5’-3’ Reverse primer sequence 5’-3’ Length in base pairs
SP-A1 TGGGTCGCTGATTTCTTGGA CGCTGCTCTCACTGACTCA 82
SP-A2 TGAAAAGAAGGAGCAGCGACT ACCAGGGCTTCCAACACAA 126
SP-D AATGGCAAGTGGAATGACAGG CACCCCAGTTGGCTCAGAA 73
OTR TTACAATCACTAGGATGGCTACAA CATTTACATTCCCACCAACAATTTAA 105
C43 TGGATTCAGCTTGAGTGCTG GGTCGCTCTTTCCCTTAACC 130
COX2 CAAATCATCAACACTGCCTCAAT TCTGGATCTGGAACACTGAATG 89
mTOR TGCCAACTATCTTCGGAACC GCTCGCTTCACCTCAAATTC 114
Deptor CACCATGTGTGTGATGAGCA TGAAGGTGCGCTCATACTTG 101
doi:10.1371/journal.pone.0143379.t001
Surfactant Proteins SP-A and SP-D Modulate Uterine Contractile Events
PLOS ONE | DOI:10.1371/journal.pone.0143379 December 7, 2015 4 / 18
Cells were then blocked in 5% FCS/PBS (v/v) and incubated with anti-human SP-A or SP-D
polyclonal antibodies diluted in 5% FCS/PBS (v/v) for 45 min. The rabbit anti-human SP-A
and SP-d polyclonal antibodies were raised against sequenced verified native SP-A and SP-D
(purified from lung lavage) in the laboratory of Prof KBM Reid, MRC Immunochemistry Unit,
University of Oxford. Coverslips were washed with 5% FCS/PBS (v/v) before being incubated
with a staining solution that consisted of Alexafluor 568 secondary anti-rabbit antibody, phal-
loidin 488 and Hoechst (Invitrogen, Life Technologies), for 45 min in the dark. After washing
with 5% FCS/PBS, the coverslips were mounted on slides and visualised on a HF14 Leica
DM4000 microscope.
ImageStream flow cytometry
A confluent 75cm2 flask of ULTR cells was split evenly into eppendorf tubes, which were cen-
trifuged at 1500 rpm for 5 minutes. The supernatant was discarded and the pellet was washed
with sterile PBS, followed by another spin for 3 minutes at 2000 rpm. Cells were fixed in 4%
PFA for 7 minutes on ice and then centrifuged for 5 minutes at 1500 rpm. The pellet was
washed with PBS and spun at 2000 rpm for 3 minutes. Cells were blocked for 30 minutes in
FBS-PBS and then centrifuged at 2000 rpm for 3 minutes. The pellet was incubated overnight
with primary antibody (SP-A or SP-D) diluted in FBS-PBS (1:200) at 4°C. After incubation,
cells were centrifuged at 2000 rpm for 3 minutes and then washed with PBS. Secondary HRP
conjugated anti-rabbit antibody, diluted in FBS-PBS (1:200) was added to the cells for a 30
minute-incubation. The cells were centrifuged and washed once more as described above.
Accumax (Sigma) and DRAQ5 were added before visualising in the ImageStream. Compensa-
tion samples that only contained antibodies or only DRAQ5, were used for data normalisation.
Data and images were analysed using an ImageStreamx Mark II Imaging Flow Cytometer
(Amnis, Merck Millipore).
Live cell imaging
ULTR cells at 80% confluency were detached from the surface of the flask and a specific
amount of cells so as to reach confluency between 30–40% was transferred into petri dishes.
Cells were treated with rhSP-A or rhSP-D at a final concentration of 10 μg/ml. Cells were left
to adhere for approximately 6 h before being placed under a Zeiss Axiovert 200M microscope
that had an incubator attached to allow cell survival and to visualise cell motility. After an area
with approximately 20–30 cells was found, pictures of the cells were recorded every 5 min for
15 h. The results from the first 8 h were then used to determine cell motility. X and Y coordi-
nates generated through ImageJ were acquired for 25 cells. Distance was calculated using
Pythagoras’ theorem, and velocity and displacement were also determined for each treatment.
Wound healing assay
Cells were grown and detached as mentioned above, transferred to a petri-dish, and then
allowed to reach 100% confluency. Using a fine tip, the bottom of each well was scratched in
three different places to create a gap. Cells were placed under a Zeiss Axiovert 200M micro-
scope and images were recorded every 5 min over 48 h for untreated as well as treated cells
with rhSP-A or rhSP-D.
Collagen contraction assay
Cells were seeded at a specific density in a 24 well plate. To form the collagen discs as described
previously [23], 150,000 cells were mixed with a neutral solution consisting of collagen from
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bovine skin (Sigma-Aldrich, U.S.A), 10 x PBS and water. The cell-collagen solution was then
loaded to a 24-well plate. Wells with no treatments and no cells were used as a control. The
plates were incubated for approximately 2 h at 37°C to allow polymerisation. By using a fine
pipette tip (1–10μl) and scoring around the edge carefully, the collagen discs were released
from the sides of the wells. Cells were treated with rhSP-A or rhSP-D (10 μg/ml). Using a
BioRad machine, images were captured post-treatment at zero min (at time of treatment),
3 and 24 h. The software ImageJ was used to measure the surface area changes.
Myltiplex cytokine array analysis
Concentrations of the following human cytokines and chemokines (CD40, EGF, ENA-78, FGF
basic, G-CSF, GM-CSF, GROα, IFN-γ, IL-1α, IL-1β, IL-1ra, IL-1 RII, IL-2, IL-3, IL-4, IL-5, IL-
6ra, IL-6, IL-8, IL-10, IL-12 p70, IL-15, IL-17, IL-19, IL-27, IL-31, IP-10, MIP-1α, MIP-1β,
TNF-α and VEGF) were measured by MagPix Milliplex kit (EMDMillipore, U.S.A). Magnetic
beads coupled to specific analytes were incubated with the supernatant of myometrium cells
treated with rhSP-A or rhSP-D at different time points and doses, and assay buffer. The sam-
ples were loaded on a 96 well plate and kept at 4°C for 18 h. After a series of washes, detection
antibodies were incubated with the magnetic beads for 1 hour at room temperature and then
with a Streptavidin-Phycoerythrin conjugate for 30 min. Finally, sheath fluid was added to
each well and the plate was using the Luminex Magpix instrument, according to manufactur-
er’s instructions.
Statistical analysis
Graphs were compiled and statistical analysis was acquired using Graphpad Prism 5.0. Normal
distribution was identified using the f test. If data was equally distributed then to identify signif-
icance between treatments and time points for the experiments, a student’s t-test was per-
formed (p<0.05, p<0.01, p<0.001) between treated and control samples but also
between different treatments. When the data was not equally distributed, Mann-Whitney U
test was used. Error bars represent the standard deviation for each group of data, apart from
Fig 2 where error bars represent the standard error of the mean.
Results
SP-A and SP-D affect the cell motility of myometrial cells
During gestation the myometrium goes through a phase of increased production of extracellu-
lar matrix proteins and subsequent increase of smooth muscle cell size [24]. It was therefore
important to assess the effects of SP-A and SP-D on cell motility. ULTRs were treated with
rhSP-A or rhSP-D (10 μg/ml) in a petri-dish and photographs of the cells were taken every
5 min for 12 h. Images from the first 8 h were used for the analysis. Individual cell movements
were tracked using ImageJ that provided the coordinates for each point. About 25 cells were
tracked for each experiment, including no supplement. Both rhSP-A and rhSP-D were able to
increase the distance and the velocity of ULTR cells compared to untreated cells (Fig 2A and
2B); with rhSP-A having a more profound effect on velocity and distance (1.4 fold) than
rhSP-D. rhSP-A increase was also significant compared to the rhSP-D treated cells. Moreover,
both proteins induced significantly cell displacement (Fig 2C). There was no apparent signifi-
cance in between treatments.
The human myometrium also differentiates in terms of cell number and size in two distinct
stages of pregnancy: hyperplasia and hypertrophy [24]. To investigate the effects of SP-A and
SP-D on cell proliferation, ULTRs were treated for 24 h with 10 μg/ml of rhSP-A and rhSP-D.
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Cell count analyses demonstrated a modest increase of cell proliferation in the rhSP-D treated
cells, whereas treatment with rhSP-A did not have any effect compared to control (data not
shown).
SP-A and SP-D augment uterine wound healing
Few histopathologic studies on uterine wound healing have been reported. To further investi-
gate the functional effects of surfactant proteins on myometrium cells, a wound was created
within the confluent cells growing on a petri-dish. Images of the cells were taken every 10 min
for up to 48 h and the distance of the gap was measured. The untreated cells (Fig 3A) failed to
close the gap even after 48 h (Fig 3D), whereas the cells treated with rhSP-A (Fig 3B) closed the
gap after only 17 h (Fig 3E) and cells treated with rhSP-D (Fig 3C) after 25 h (Fig 3F).
SP-A and SP-D induce myometrial contractility in vitro
The human myometrium is mostly in a quiescent state during the gestational period and
becomes contractile during labour stages. There have been numerous studies regarding the
mechanisms involved the transition from quiescent to a contractile state using in vitro and ex
vivo models [25, 2]. To date, no data is available regarding the impact of SP-A and SP-D on
this physiological response. Therefore, to assess the effects of rhSP-A and rhSP-D on contractil-
ity, cells were grown on 3D collagen matrices, and then treated with 10 μg/ml of rhSP-A or
rhSP-D. The surface area of the collagen discs was measured using ImageJ at 3 and 24 h post-
treatment. After 3 h, the area of the collagen disc of the cells treated with rhSP-A was 66%
smaller, whereas the area of the disc treated with rhSP-D was 70% smaller compared to the
untreated cells (Fig 4A). The effect was evident even after 24 h with surface areas similar but
only slightly increased (62% and 67% smaller compared to the untreated cells respectively).
There was no significant surface area change between treatments or time-points (3 and 24 h)
post-treatment.
Modulation of mRNA expression of pro-labour mediators and genes
involved in myometrial reconditioning by SP-A and SP-D
To investigate the effects of surfactant proteins on the contractile machinery we treated ULTR
cells with rhSP-A and rhSP-D at different concentrations and RNA was then extracted at 0, 4,
6 and 12 h. We then set out to determine the relative amounts of oxytocin receptor (OXTR),
gap junction protein connexin 43 (CX43), cyclo-oxygenase 2 (COX2), mechanistic Target of
Rapamycin (mTOR), DEPTOR and human SP-A, SP-D mRNAs. We chose the above men-
tioned panel of genes since CX43, OXTR and COX2 are pro-labour mediators expressed in
human myometrium, whereas mTOR plays an important role in myometrial reconditioning
[24]. Finally, we also investigated the impact of these treatments on the expression of SP-A and
SP-D themselves.
rhSP-A treatments resulted in an increase of CX43 mRNA expression at a concentration of
10 and 20 μg/ml after 4 h, compared to the untreated cells, an effect that appeared to disappear
Fig 2. Representation of the average distance (A), velocity (B) and displacement (C) comparisons in
ULTR treated with and without rhSP-A and rhSP-D (*p<0.05, **p<0.01, ***p<0.001).Cell movements
(n = 25 cells, from a single experiment) were observed either without treatment or with treatment with
surfactant proteins (10 μg/ml). Both treatments led to a significant increase in velocity, distance travelled and
their displacement from their initial position compared to untreated cells. rhSP-A treatment led to a significant
increase in velocity and distance compared to rhSP-D treated cells. There was no apparent significance in
displacement in between treatments.
doi:10.1371/journal.pone.0143379.g002
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after 6 h (Fig 5A). rhSP-A treatment also resulted in an increase of OXTR mRNA at a concen-
tration of 10 and 20 μg/ml after 6 h compared to the untreated cells (Fig 5B). rhSP-D had a
more profound effect on the CX43 transcript production at all doses after 6 h of treatment
(Fig 5C). rhSP-D treatments led to an increase of OXTR mRNA expression at a concentration
of 10 μg/ml after 6 h (Fig 5D), compared to the untreated cells, an effect that appeared to disap-
pear after 12 h (data not shown).
Using immunofluorescent analysis we demonstrate that ULTR cells express SP-A (Fig 6A–
6C) and SP-D (Fig 6D–6F) aberrantly, with a predominant cytoplasmic localisation. We
expanded on these analyses using high-power imaging technology. We have measured over
10,000 using ImageStream and it is evident that the expression is primarily on the cytoplasm
for both proteins (Fig 6G and 6H). There was a higher fluorescence intensity SP-D immunos-
tained cells appeared to to SP-A immunostained ULTR cells (Fig 6I).
Under the same treatment conditions of ULTR cells, a biphasic response was observed.
rhSP-D induced mRNA expression of human SP-A1 (Fig 7A), SP-A2 (Fig 7B) and SP-D (Fig
7C) at a concentration of 5, 10 and 20 μg/ml at 6 h, followed by a moderate, but significant,
decrease at 12 h post-treatment. rhSP-A led to a decrease in the expression of the SP-A tran-
scripts after 6 h but did not have an effect on SP-D mRNA expression (rhSP-A data not
shown). Treatments with either protein did not seem to affect the expression levels of COX2
(data not shown). Recent studies from our laboratory have also shown that the human
Fig 3. Wound healing assay usingmyometrium cells untreated (A), and treated with rhSP-A (B) and rhSP-D (C) at 0 and 48 h time points (D, E, and
F respectively). Untreated cells (A) failed to close the gap even after 48 h (D), whereas the cells treated with rhSP-A (B) closed the gap after 17 h (E) while
those treated with rhSP-D (C) after 25 h (F). Dotted rectangular annotates the area covered by treated ULTRs. Gap that was less than 3 cells apart was
considered as closed. x 10 magnification.
doi:10.1371/journal.pone.0143379.g003
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myometrium differentially expresses mTOR signaling components. mTOR and DEPTOR
mRNA levels did not seem to alter following treatment with either rhSP-A or rhSP-D (data not
shown).
Induction of growth factors and cytokines by rhSP-A and rhSP-D
To investigate the effects of surfactant protein treatments on the cytokine expression in ULTR
cells, a multiplex cytokine array was used. FGF and VEGF play a key role in various cell devel-
opmental and pathophysiological changes in vivo and in vitro [26]. rhSP-A did not seem to
affect the expression levels of either FGF or VEGF, whereas rhSP-D induced secretion of both
cytokines/growth factors. Surprisingly, treatments with rhSP-A and rhSP-D appeared to have
little or no effect on the secretion of IFN-γ, TNF-α and IL-1β which are important pro-inflam-
matory cytokines during the first trimester of pregnancy [27]. Both treatments led to an
increase of ENA-78, also called C-X-C motif cytokine 5, which is concurrently expressed with
IL-8 and promotes angiogenesis and tissue remodelling [28]. Treatments with rhSP-A led to an
increase in the expression of GROα (a chemokine elevated in preterm labour) after 12 h at
Fig 4. Surface disc area comparisons betweenmyometrium cells growing in collagen with or without treatment with rhSP-A or rhSP-D, after 3 and
24 h. Cells were seeded at a specific density and were grown in a collagen matrix to mimic a 3Dmilieu. rhSP-A and rhSP-D significantly induced a similar
contractility of ULTR cells compared to untreated cells, at 3 and 24 h (A), (*p<0.05, **p<0.01, ***p<0.001). There was no significance in between treatments
or time points. Representative collagen discs of 3 h treatment (B; NS: no supplement). Insert: image of ULTRs grown within the collagen matrix (n = 4).
doi:10.1371/journal.pone.0143379.g004
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10 and 20 μg/ml (1.2 and 1.4-fold respectively). rhSP-D treatments (10 and 20 μg/ml) led to a
1.4 and a 1.3-fold change respectively after 12 h and a 1.5 and 1.4-fold change after 24 h (Fig
8A). Our treatments had a similar effect on the pro-inflammatory cytokines IL-6 and IL-8.
rhSP-D treatments at both concentrations appeared to result in an increase of IL-6 expression
(1.3-fold change at 10 μg/ml, 1.2-fold change at 20 μg/ml after 12 h and a 1.3-fold change at
10 μg/ml, 1.4-fold change at 20 μg/ml after 24 h). IL-8 expression was increased by 2.3-fold at
both concentrations at 12 h in ULTR cells treated with rhSP-A, whereas ULTR treated cells
with rhSP-D increased expression of IL-8 by 1.8 and 1.9-fold at 12 h and by 2-fold at 24 h
(Fig 8B–8D). IL-6 and IL-8 have been shown to promote immune infiltration, angiogenesis
Fig 5. Relative quantification comparisons of CX43 and OXTR in ULTR cells treated with 5, 10 and 20 μg/ml of rhSP-A (A-B) and rhSP-D (C-D) after
4 and 6 h (*p<0.05, **p<0.01, ***p<0.001). rhSP-A led to an increase of CX43 mRNA expression after 4 h at a concentration of 10 and 20 μg/ml, effect
that seemed to disappear after 6 h, and of OXTR after 6 h at concentrations of 10 and 20 μg/ml. rhSP-D resulted in an increase of CX43 transcript at all
concentrations, and of OXTR transcript after 6 h at a concentration of 5 μg/ml (n = 3). Letter denotes values significantly different from each other as indicated
by the horizontal and vertical lines (p<0.05).
doi:10.1371/journal.pone.0143379.g005
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and regulate various aspects of the immune response [29]. In addition, levels of IL-6 Ra, which
is a soluble receptor that binds to IL-6 in solution and augments its activity, were also increased
after treatment with rhSP-D after 12 h (1.1-fold increase) and 24 h (1.3-fold increase) com-
pared to the control (Fig 8C).
Discussion
It has been proposed that surfactant proteins SP-A and SP-D secreted into the amniotic fluid
can play a key role in parturition. In this study, we elucidated the effects of SP-A and SP-D
using a human myometrial cell line as an experimental model. For this study we have decided
to use the myometrial ULTR cell line, since due to ethical considerations we could not obtain
primary myometrial cell cultures. ULTR is is a smooth muscle cell line that expresses all the
Fig 6. Immunofluorescent analysis of ULTRs, immunostained for SP-A (A) and SP-D (D). Nuclear staining using phalloidin 488 for SP-A (B) and SP-D
(E). Merged images for SP-A (C) and SP-D (F). x 40 magnification. (G) and (H): Representative cells immunostained for SP-A and SP-D respectively.
Merged image (I) showing the comparison of the fluorescence intensity of the cells between SP-A (red) and SP-D (black). SP-D immunostained cells
appeared to have higher intensity compared to SP-A immunostained cells.
doi:10.1371/journal.pone.0143379.g006
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key components of the myometrium and maintains the features of primary human myometrial
cells [30]. Moreover, previous studies have used this in vitromodel to study myometrial func-
tion and cytokine release as they have similar response as primary myometrial cells [30, 31]. In
the future, it will be of interest to repeat these experiments in primary human myometrial cells.
Fig 7. Relative quantification comparisons of SP-A1 (A), SP-A2 (B), and SP-D (C) in ULTR treated with
5, 10 and 20 μg/ml of rhSPD after 6 and 12h (*p<0.05, **p<0.01, ***p<0.001). rhSP-D treatments
resulted in an increase of SP-A1, SP-A2 and SP-D mRNA expression at 6 h at 5 and 10 μg/ml. The effect was
inverted at 12 h, with rhSP-D leading to a decrease in the expression of the above genes (n = 3).
doi:10.1371/journal.pone.0143379.g007
Fig 8. Multiplex cytokine array analysis of the supernatants of ULTR cells treated with rhSPA or rhSPD at different concentration time points
(n = 2). Secretion levels for GROα (A), IL-6 (B), IL-6 Ra (C) and IL-8 (D), were measured by a MagPix Milliplex kit (EMDMillipore) rhSP-A treatments (10 and
20 μg/ml) caused an increase in the expression of GROα and IL-8 compared to the untreated cells, but did not have a profound effect on IL-6 and IL-6Ra.
rhSP-D treated cells (10 and 20 μg/ml) appeared to express higher levels of GROα, IL-6 and IL-8 at 12 and 24 h compared to the untreated cells. ULTR cells
treated with rhSP-D (10 and 20 μg/ml) expressed higher levels of IL-6 Ra after 24h. (*p<0.05, **p<0.01, ***p<0.001). Letter denotes values significantly
different from each other as indicated by the horizontal and vertical lines (p<0.05).
doi:10.1371/journal.pone.0143379.g008
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We demonstrate that the human myometrium is a source of SP-A and SP-D, and that they
can affect cell motility, and trigger contractility by inducing contraction-associated protein
(CAP) genes such as OXTR and CX43 and augmenting the secretion of pro-inflammatory
cytokines, such as IL-6 and IL-8.
The myometrium undergoes substantial changes in phenotype during the gestational
period. It begins with a proliferative phase, followed by cellular hypertrophy and remodelling
of matrix, and finally a phase where myometrial cells acquire a contractile phenotype and drive
events that lead to labour and parturition [2, 24]. Here we demonstrate that both rhSP-A and
rhSP-D were able to increase distance and velocity and cell displacement of myometrial cells.
In the wound healing assay where ULTR cells treated with rhSP-A closed the gap at 17 h
whereas ULTR cells treated with rhSP-D did so after 25 h. These data indicate that both SP-A
and SP-D can play an important role in the reconditioning of the uterus particularly during the
intermediate synthetic phase. Our data are further corroborated by initial studies where SP-A
was able to induce F-actin stress fibres in primary myometrial cells [32]. Collectively, these
findings suggest that SP-A in particular can play a key role in myometrial cytoskeleton reorga-
nisation. A number of studies have shown that surfactant proteins are present in intra-uterine
tissues including myometrium [32, 33], amniotic fluid and fetal membranes [16], decidua and
placenta [15]. It is possible therefore that these peptides can exert their effects in an autocrine
or paracrine manner. For example, corticotropin releasing hormone is produced in a similar
fashion from a number of intra-uterine organs–including the myometrium, decidua and pla-
centa- and exerts its effects in endocrine, paracrine and autocrine manner [34, 35].
The mechanistic target of Rapamycin (mTOR) appears to be involved in the reconditioning
of the myometrium during early stages of gestation in rodents [36]. Moreover, we have shown
that the human myometrium differentially expresses mTOR signaling components that are
regulated by steroids [24]. When myometrial cells were treated with rhSP-A or rhSP-D, no
apparent changes on mTOR or DEPTOR gene expression were noted. Further studies are
needed to investigate whether SP-A and SP-D can affect mTORC1 activity by changing the
phosphorylation status of key proteins like mTOR or S6K.
We also assessed the effects of both surfactant proteins on contraction-associated protein
(CAP) genes. rhSP-A and rhSP-D induced the expression of OXTR and CX43 at 4 and 6 h.
The induction of CX43 was greater than that of OXTR by at least 2-fold. Interestingly, female
mice doubly deficient in SP-A and SP-D (SP-A/D-/-) have been shown to exhibit significantly
lower levels of OXTR and CX43 at 18.5 dpc compared with wild-type (WT) in their myome-
trium [37]. We expanded further on these observations by measuring an actual contractile
response using myometrial cells grown on 3D collagen matrices. At 3 h post-treatment, there
was a dramatic induction in contractility, an effect sustained up to 24 h. Both surfactant pro-
teins elicited a similar degree of response. These novel data using a 3D human in vitro model
corroborate previous in vivo studies in mice where intraamniotic injection of SP-A at 15.5 dpc
caused preterm delivery of foetuses within 6 to 24 h. By contrast, injection of an SP-A antibody
into the amniotic sac of mice delayed labour by more than 24 h [18]. In a more recent study
using SP-A/D-/- mice, females delivered at term (*19.5 dpc) in their first pregnancy, but in
their second pregnancies, parturition was delayed by approximately 12 h [37].
Both term and preterm labour are associated with increased levels of pro-inflammatory
cytokines such as IL-1β, IL-6, IL-8, and TNF-α in maternal sera and reproductive tissues [38].
Preterm birth, in particular, can affect up to 18% of pregnancies and is a leading cause of infant
morbidity and mortality [39]. Here we have used conditioned media from myometrial cells
treated with SP-A and SP-D and assayed a wide repertoire of cytokines using a multiplex cyto-
kine array. Cytokines that were raised included GRO alpha (GROα), ENA-78, IL-6 Ra, IL-6
and IL-8. This is of particular significance since GROα has a chemotactic activity for
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neutrophils. Królak-Olejnik et al., have shown that GROα is lower in full-term infants than in
preterm ones [40]. More importantly, the key pro-inflammatory cytokine, IL-8, was also raised
by rhSP-A and rhSP-D. In rhSP-D treated cells, there was also a noted increase in IL-6 and the
soluble IL-6 Rα that can potentially bind to IL-6 in solution and augment the activity of IL-6.
In the SP-A/D-/- mice, IL-6 levels were reduced in the myometrium but not in the amniotic
fluid when compared to wild type female mice [37]. In a more recent study, it was shown that
co-culture of monocytes and myocytes induces an increased pro-inflammatory response and
myometrial contraction, involving IL-6 and IL-8h [41]. Future studies should make use of full
length recombinant SP-A and SP-D, together with full length native C1q to provide a further
insight into their role at myometrial level.
In summary, our novel findings provide conclusive evidence for a key role of both SP-A and
SP-D in reconditioning the human myometrium and inducing CAP genes and inflammatory
cytokines. This is intended to cause a shift of the uterus from a quiescent state to a contractile
one leading to parturition.
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